Quarter of Europeans have had a Covid-19 jab


A quarter of the European Union’s population have received at least one COVID-19 vaccine jab, prompting EU chief Ursula von der Leyen to say the bloc is on track to have 70 percent of adults immunised by late July.

The milestone showed that Europe was now surging ahead in vaccinations following a lacklustre first-quarter rollout that was starved of doses because of a shortfall in deliveries by AstraZeneca.

As of mid-Tuesday, 25.1 percent of the EU’s population of 446 million had received at least one injection, according to an AFP tally collated from official health figures from each EU country.

“Vaccination is gaining speed across the EU: we have just passed 150 million vaccinations,” von der Leyen tweeted.

“A quarter of all Europeans have had their first dose. We’ll have enough doses for vaccinating 70% of EU adults in July.”

AFP’s collected data show 112 million people in Europe had received at least one jab, with more than 153.8 million doses administered. At least 41.9 million people were fully vaccinated, amounting to 9.4 percent of the population.

The heightened pace means the EU can expect to see 70 percent of its 365 million adults immunised by late July.

That target has been brought forward two months, largely because of sped-up deliveries of the BioNTech/Pfizer vaccine, accounting for a large proportion of the jabs given in the 27 EU countries.

Poorer countries struggling

The EU has started legal action against AstraZeneca for falling far short of its promised delivery of doses.

It has thrown its weight behind the mRNA technology used by BioNTech/Pfizer, holding negotiations for an extra 1.8 billion doses of its second-generation vaccine to cope with variants, inoculate older children, and to export to non-EU countries in need.

While the EU is now bounding forward with its vaccination programme, it still trails wealthy countries the United States and Britain in administering injections. All three invested funds last year to ensure access to promising vaccines.

The US has 31.9 percent of its population completely vaccinated. In Britain, it is 22.8 percent.

Israel, which has led the world, has 58.5 percent of its relatively small population fully vaccinated.

Poorer countries, by contrast, are struggling to get their hands on doses for their own populations, although the World Health Organization-backed Covax facility is working to bring them deliveries—mostly of the AstraZeneca vaccine.

Source: Read Full Article

Poll shows plunge in Europeans’ trust in AstraZeneca jab


Trust in AstraZeneca’s coronavirus vaccine in many European countries has plunged following controversy around the jab in recent weeks, according to a new survey unveiled Monday by British pollsters YouGov.

A majority of people in the biggest European Union member states, including Germany, France, Spain and Italy, now see the inoculation as unsafe, the recent poll found.

However, views of the Anglo-Swedish pharma giant’s jab remain overwhelming positive in Britain, where two-thirds of respondents said it is safe, compared to just nine percent believing it is not.

The findings come at a tumultuous time for the AstraZeneca vaccine and the EU’s troubled inoculation campaign, as a third virus wave on the continent prompts renewed social restrictions.

Meanwhile, Britain and the bloc are embroiled in an increasingly acrimonious war of words over supplies, with Brussels warning it may halt AstraZeneca vaccine exports.

The drop in Europeans’ faith in the jab, developed in partnership with Oxford University in the UK, follows weeks of turmoil on the continent over safety fears.

Earlier this month several EU countries suspended its use, pending a review by the European Medicines Agency (EMA) after dozens of isolated cases of blood clots and brain haemorrhages.

The EMA last week declared the AstraZeneca jab “safe and effective”, with the WHO and Britain’s drugs watchdog issuing similar endorsements.

That led European countries to resume administering the vaccine, but not before severely damaging confidence in it.

‘Undoubtedly suffered’

In its mid-March survey, YouGov found 55 percent of Germans now say the vaccine as unsafe—a 15 point rise in a month—compared to 32 percent viewing it as safe.

In already more vaccine-hesitant France, 61 percent of respondents said it was unsafe, while Italy and Spain both saw a 27-point monthly jump in the number of people saying they did not trust the jab.

No similar increases in safety fears were seen for rival vaccines by Pfizer and Moderna, YouGov said.

The pollsters interviewed 2,024 Germans, and around 1,000 adults in each of the other countries between March 12 and 18.

“After concerns about its protection and potency were raised by leaders across Europe, the Oxford/AstraZeneca vaccine has undoubtedly suffered damage to its reputation for safety on the continent,” said Matt Smith, lead data journalist at YouGov.

“With a third wave of infections potentially emerging now across the Channel, officials everywhere will be worried if ongoing rows about AstraZeneca’s vaccine ends up damaging the rollout.”

Even prior to its recent woes in Europe, the jab—which is among the cheapest available, relatively easy to store and billed as the vaccine of choice for poorer nations—had suffered several setbacks.

They include South Africa asking to send back one million doses after researchers found it had failed to prevent mild and moderate cases of a more contagious virus variant there.

Confidence in the vaccine has also been hit by mixed messaging.

Source: Read Full Article